Literature DB >> 27526678

Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items.

Rosalind A Lees1, Kirsty Hendry Ba1, Niall Broomfield2, David Stott1, Andrew J Larner3, Terence J Quinn1.   

Abstract

OBJECTIVES: Cognitive screening is recommended in stroke, but test completion may be complicated by stroke related impairments. We described feasibility of completion of three commonly used cognitive screening tools and the effect on scoring properties when cognitive testing was entirely/partially incomplete.
METHODS: We performed a cross-sectional study, recruiting sequential stroke patient admissions from two University Hospital stroke rehabilitation services. We assessed Folstein's mini-mental state examination (MMSE), Montreal cognitive assessment (MoCA) and Addenbrooke's cognitive examination (ACE-III). The multidisciplinary team gave an independent diagnostic formulation. We recorded numbers fully/partially completing tests, assistance and time required for testing. We calculated test discrimination metrics in relation to clinical assessment using four differing statistical approaches to account for incomplete testing.
RESULTS: We recruited 51 patients. Direct assistance to complete cognitive tests was required for 33 (63%). At traditional cut-offs, the majority screened "positive" for cognitive impairment (ACE-III: 98%; MoCA: 98%; MMSE: 81%). Comparing against a clinical diagnosis, ACE-III and MoCA had excellent sensitivity but poor specificity. Partial completion of cognitive tests was common (ACE-III: 14/51, MMSE: 22/51; MoCA: 20/51 fully complete); greatest non completion was for test items that required copying or drawing. Adapting analyses to account for these missing data gave differing results; MMSE sensitivity ranged from 0.66 to 0.85, and specificity ranged from 0.44 to 0.71 depending on the approach employed.
CONCLUSIONS: For cognitive screening in stroke, even relatively brief tools are associated with substantial incompletion. The way these missing data are accounted for in analyses impacts on apparent test properties. When choosing a cognitive screening tool, feasibility should be considered and approaches to handling missing data made explicit.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  feasibility; screening; sensitivity; specificity; stroke

Mesh:

Year:  2016        PMID: 27526678     DOI: 10.1002/gps.4568

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  21 in total

1.  Active case finding of dementia in ambulatory care settings: a comparison of three strategies.

Authors:  T M Liew
Journal:  Eur J Neurol       Date:  2020-06-16       Impact factor: 6.089

2.  European Stroke Organisation and European Academy of Neurology joint guidelines on post-stroke cognitive impairment.

Authors:  Terence J Quinn; Edo Richard; Yvonne Teuschl; Thomas Gattringer; Melanie Hafdi; John T O'Brien; Niamh Merriman; Celine Gillebert; Hanne Huyglier; Ana Verdelho; Reinhold Schmidt; Emma Ghaziani; Hysse Forchammer; Sarah T Pendlebury; Rose Bruffaerts; Milija Mijajlovic; Bogna A Drozdowska; Emily Ball; Hugh S Markus
Journal:  Eur Stroke J       Date:  2021-10-08

3.  The impact of early-life intelligence quotient on post stroke cognitive impairment.

Authors:  Stephen Dj Makin; Fergus N Doubal; Kirsten Shuler; Francesca M Chappell; Julie Staals; Martin S Dennis; Joanna M Wardlaw
Journal:  Eur Stroke J       Date:  2018-01-08

4.  Rates, risks and routes to reduce vascular dementia (R4vad), a UK-wide multicentre prospective observational cohort study of cognition after stroke: Protocol.

Authors:  Joanna M Wardlaw; Fergus Doubal; Rosalind Brown; Ellen Backhouse; Lisa Woodhouse; Philip Bath; Terence J Quinn; Thompson Robinson; Hugh S Markus; Richard McManus; John T O'Brien; David J Werring; Nikola Sprigg; Adrian Parry-Jones; Rhian M Touyz; Steven Williams; Yee-Haur Mah; Hedley Emsley
Journal:  Eur Stroke J       Date:  2020-10-11

5.  Addenbrooke's Cognitive Examination III (ACE-III) and mini-ACE for the detection of dementia and mild cognitive impairment.

Authors:  Lucy C Beishon; Angus P Batterham; Terry J Quinn; Christopher P Nelson; Ronney B Panerai; Thompson Robinson; Victoria J Haunton
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

6.  AD-8 for detection of dementia across a variety of healthcare settings.

Authors:  Kirsty Hendry; Claire Green; Rupert McShane; Anna H Noel-Storr; David J Stott; Sumayya Anwer; Alex J Sutton; Jennifer K Burton; Terry J Quinn
Journal:  Cochrane Database Syst Rev       Date:  2019-03-04

7.  Efficacy of alogliptin combined with motor imagery under hyperbaric oxygen in diabetic nephropathy with silent cerebral infarction.

Authors:  Danyan Chen; Xiaolong Huang; Hua Gan; Xiaogang Du; Song Lu; Rongxi Huang; Ke Liu; Binghan Zhang
Journal:  Biomed Rep       Date:  2017-09-14

Review 8.  Post-stroke dementia - a comprehensive review.

Authors:  Milija D Mijajlović; Aleksandra Pavlović; Michael Brainin; Wolf-Dieter Heiss; Terence J Quinn; Hege B Ihle-Hansen; Dirk M Hermann; Einor Ben Assayag; Edo Richard; Alexander Thiel; Efrat Kliper; Yong-Il Shin; Yun-Hee Kim; SeongHye Choi; San Jung; Yeong-Bae Lee; Osman Sinanović; Deborah A Levine; Ilana Schlesinger; Gillian Mead; Vuk Milošević; Didier Leys; Guri Hagberg; Marie Helene Ursin; Yvonne Teuschl; Semyon Prokopenko; Elena Mozheyko; Anna Bezdenezhnykh; Karl Matz; Vuk Aleksić; DafinFior Muresanu; Amos D Korczyn; Natan M Bornstein
Journal:  BMC Med       Date:  2017-01-18       Impact factor: 8.775

9.  Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting.

Authors:  Calvin Ch Chan; Bruce A Fage; Jennifer K Burton; Nadja Smailagic; Sudeep S Gill; Nathan Herrmann; Vasilis Nikolaou; Terry J Quinn; Anna H Noel-Storr; Dallas P Seitz
Journal:  Cochrane Database Syst Rev       Date:  2019-09-14

10.  Mini-Cog for the detection of dementia within a secondary care setting.

Authors:  Calvin Ch Chan; Bruce A Fage; Jennifer K Burton; Nadja Smailagic; Sudeep S Gill; Nathan Herrmann; Vasilis Nikolaou; Terry J Quinn; Anna H Noel-Storr; Dallas P Seitz
Journal:  Cochrane Database Syst Rev       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.